Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
Article
Iron chelator CP94 enhances nodular BCC response to PDT
Washington - Enhanced 5-aminolevulinic acid photodynamic therapy (ALA PDT) performed with use of the novel iron chelator CP94 shows promise for improving the efficacy of topical PDT for nodular basal cell carcinoma (BCC), said Colin A. Morton, M.D., at the annual meeting of the American Academy of Dermatology.
Related Videos
Related Content
